Lymphocyte glucocorticoid receptor expression level and hormone-binding properties differ between war trauma-exposed men with and without PTSD

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 43, Issue , 2013, Pages 238-245

  Matić, Gordana ^a   Milutinović, Danijela Vojnović ^a   Nestorov, Jelena ^a   Elaković, Ivana ^a   Jovanović, Sanja Manitašević ^a   Perišić, Tatjana ^a   Dunderski, Jadranka ^a   Damjanović, Svetozar ^a   Knežević, Goran ^a,b   Špirić, Željko ^b,c   Vermetten, Eric ^d   Savić, Danka ^b,e  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b International Aid Network   (Serbia)

^c UNIVERSITY OF DEFENCE   (Serbia)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Glucocorticoid receptor; Peripheral blood mononuclear cells; PTSD; Resilience to PTSD; War trauma

Indexed keywords

GLUCOCORTICOID RECEPTOR; LYMPHOCYTE GLUCOCORTICOID RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BATTLE INJURY; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE; GENE EXPRESSION; HORMONE BINDING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LYMPHOCYTE GLUCOCORTICOID RECEPTOR GENE; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; POSTTRAUMATIC STRESS DISORDER; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS;

ADULT; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; DEXAMETHASONE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLUCOCORTICOIDS; HORMONES; HUMANS; KINETICS; LYMPHOCYTES; MALE; MIDDLE AGED; MURAMIDASE; RADIOLIGAND ASSAY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, GLUCOCORTICOID; SERBIA; STRESS DISORDERS, POST-TRAUMATIC; WAR; WOUNDS AND INJURIES;

EID: 84873550690     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.01.005     Document Type: Article

References (62)

1. Altemus M., Dhabhar F.S., Yang R. Immune function in PTSD. Ann N Y Acad Sci 2006, 1071:167-183.
2. Bachmann A.W., Sedgley T.L., Jackson R.V., Gibson J.N., Young R.M., Torpy D.J. Glucocorticoid receptor polymorphisms and post-traumatic stress disorder. Psychoneuroendocrinology 2005, 30:297-306.
3. Baker D.G., Ekhator N.N., Kasckow J.W., Hill K.K., Zoumakis E., Dashevsky B.A., et al. Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder. Neuroimmunomodulation 2001, 9:209-217.
4. Beck A.T., Brown G.K., Steer R.A. Beck Depression Inventory 1996, Psychological Corporation, San Antonio, TX. second ed.
5. Binder E.B. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 2009, 34(Suppl. 1):S186-S195.
6. Binder E.B., Bradley R.G., Liu W., Epstein M.P., Deveau T.C., Mercer K.B., et al. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008, 299:1291-1305.
7. Blake D.D., Weathers F.W., Nagy L.M., Kaloupek D.G., Gusman F.D., Charney D.S., et al. Clinician Administered PTSD Scale for DSM-IV: current and lifetime diagnostic version 1996, National Centre for Posttraumatic Stress Disorder, Boston.
8. Bob P., Raboch J., Maes M., Susta M., Pavlat J., Jasova D., et al. Depression, traumatic stress and interleukin-6. J Affect Disord 2010, 120:231-234.
9. Brkljačić J., Tanić N., Milutinović D.V., Elaković I., Jovanović S.M., Perišić T., et al. Validation of endogenous controls for gene expression studies in peripheral lymphocytes from war veterans with and without PTSD. BMC Mol Biol 2010, 11:26.
10. Chang L., Wang G.J., Volkow N.D., Ernst T., Telang F., Logan J., et al. Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. Neuroimage 2008, 42:869-878.
11. de Kloet C.S., Vermetten E., Bikker A., Meulman E., Geuze E., Kavelaars A., et al. Leukocyte glucocorticoid receptor expression and immunoregulation in veterans with and without post-traumatic stress disorder. Mol Psychiatry 2007, 12:443-453.
12. de Kloet C.S., Vermetten E., Geuze E., Kavelaars A., Heijnen C.J., Westenberg H.G. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review. J Psychiatr Res 2006, 40:550-567.
13. Elaković I., Perišić T., Čanković-Kadijević M., Matić G. Correlation between glucocorticoid receptor binding parameters, blood pressure, and body mass index in a healthy human population. Cell Biochem Funct 2007, 25:427-431.
14. First M.B., Gibbon M., Spitzer R.L., Janet B.W., Williams J.B.W. User's guide for the SCID-I, structured clinical interview for DSM-IV Axis I Disorders, research version 2002, Biometrics Research Department, New York State Psychiatric Institute, New York.
15. Gill J., Luckenbaugh D., Charney D., Vythilingam M. Sustained elevation of serum interleukin-6 and relative insensitivity to hydrocortisone differentiates posttraumatic stress disorder with and without depression. Biol Psychiatry 2010, 68:999-1006.
16. Gill J., Vythilingam M., Page G.G. Low cortisol, high DHEA, and high levels of stimulated TNF-alpha, and IL-6 in women with PTSD. J Trauma Stress 2008, 21:530-539.
17. Gotovac K., Sabioncello A., Rabatic S., Berki T., Dekaris D. Flow cytometric determination of glucocorticoid receptor (GCR) expression in lymphocyte subpopulations: lower quantity of GCR in patients with post-traumatic stress disorder (PTSD). Clin Exp Immunol 2003, 131:335-339.
18. Grad I., Picard D. The glucocorticoid responses are shaped by molecular chaperones. Mol Cell Endocrinol 2007, 275:2-12.
19. Hauer D., Weis F., Papassotiropoulos A., Schmoeckel M., Beiras-Fernandez A., Lieke J., et al. Relationship of a common polymorphism of the glucocorticoid receptor gene to traumatic memories and posttraumatic stress disorder in patients after intensive care therapy. Crit Care Med 2011, 39:643-650.
20. Hoge E.A., Brandstetter K., Moshier S., Pollack M.H., Wong K.K., Simon N.M. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety 2009, 26:447-455.
21. Holmstrom S., Van Antwerp M.E., Iniguez-Lluhi J.A. Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy. Proc Natl Acad Sci U S A 2003, 100:15758-15763.
22. Ismaili N., Blind R., Garabedian M.J. Stabilization of the unliganded glucocorticoid receptor by TSG101. J Biol Chem 2005, 280:11120-11126.
23. Kawamura N., Kim Y., Asukai N. Suppression of cellular immunity in men with a past history of posttraumatic stress disorder. Am J Psychiatry 2001, 158:484-486.
24. Le Drean Y., Mincheneau N., Le Goff P., Michel D. Potentiation of glucocorticoid receptor transcriptional activity by sumoylation. Endocrinology 2002, 143:3482-3489.
25. Lemieux A., Coe C.L., Carnes M. Symptom severity predicts degree of T cell activation in adult women following childhood maltreatment. Brain Behav Immun 2008, 22:994-1003.
26. Luisi B.F., Xu W.X., Otwinowski Z., Freedman L.P., Yamamoto K.R., Sigler P.B. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 1991, 352:497-505.
27. Maes M., Lin A.H., Delmeire L., Van Gastel A., Kenis G., De Jongh R., et al. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry 1999, 45:833-839.
28. Makino Y., Okamoto K., Yoshikawa N., Aoshima M., Hirota K., Yodoi J., et al. Thioredoxin: a redox-regulating cellular cofactor for glucocorticoid hormone action. Cross talk between endocrine control of stress response and cellular antioxidant defense system. J Clin Invest 1996, 98:2469-2477.
29. Okamoto K., Tanaka H., Makino Y., Makino I. Restoration of the glucocorticoid receptor function by the phosphodiester compound of vitamins C and E, EPC-K1 (L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzo pyran-6-yl hydrogen phosphate] potassium salt), via a redox-dependent mechanism. Biochem Pharmacol 1998, 56:79-86.
30. Okamoto K., Tanaka H., Ogawa H., Makino Y., Eguchi H., Hayashi S., et al. Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J Biol Chem 1999, 274:10363-10371.
31. Panarelli M., Holloway C.D., Mulatero P., Fraser R., Kenyon C.J. Inhibition of lysozyme synthesis by dexamethasone in human mononuclear leukocytes: an index of glucocorticoid sensitivity. J Clin Endocrinol Metab 1994, 78:872-877.
32. Pohjalainen T., Rinne J.O., Nagren K., Syvalahti E., Hietala J. Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo. Am J Psychiatry 1998, 155:768-773.
33. Pratt W.B., Toft D.O. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 1997, 18:306-360.
34. Roberts A.D., Moore C.F., DeJesus O.T., Barnhart T.E., Larson J.A., Mukherjee J., et al. Prenatal stress, moderate fetal alcohol, and dopamine system function in rhesus monkeys. Neurotoxicol Teratol 2004, 26:169-178.
35. Rohleder N., Joksimovic L., Wolf J.M., Kirschbaum C. Hypocortisolism and increased glucocorticoid sensitivity of pro-Inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biol Psychiatry 2004, 55:745-751.
36. Rohleder N., Wolf J.M., Wolf O.T. Glucocorticoid sensitivity of cognitive and inflammatory processes in depression and posttraumatic stress disorder. Neurosci Biobehav Rev 2010, 35:104-114.
37. Savic D., Knezevic G., Damjanovic S., Spiric Z., Matic G. The role of personality and traumatic events in cortisol levels-where does PTSD fit in?. Psychoneuroendocrinology 2012, 37:937-947.
38. Segman R.H., Shefi N., Goltser-Dubner T., Friedman N., Kaminski N., Shalev A.Y. Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Mol Psychiatry 2005, 10:500-513. [425].
39. Shalev A.Y., Videlock E.J., Peleg T., Segman R., Pitman R.K., Yehuda R. Stress hormones and post-traumatic stress disorder in civilian trauma victims: a longitudinal study. Part I: HPA axis responses. Int J Neuropsychopharmacol 2008, 11:365-372.
40. Simons S.S., Pratt W.B. Glucocorticoid receptor thiols and steroid-binding activity. Methods Enzymol 1995, 251:406-422.
41. Spector T. Refinement of the Coomassie blue method of protein quantitation. A simple and linear spectrophotometric assay for less than or equal to 0.5 to 50 microgram of protein. Anal Biochem 1978, 86:142-146.
42. Spivak B., Shohat B., Mester R., Avraham S., Gil-Ad I., Bleich A., et al. Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorder. Biol Psychiatry 1997, 42:345-348.
43. Su T.P., Zhang L., Chung M.Y., Chen Y.S., Bi Y.M., Chou Y.H., et al. Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders. J Psychiatr Res 2009, 43:1078-1085.
44. Tian S., Poukka H., Palvimo J.J., Janne O.A. Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. Biochem J 2002, 367:907-911.
45. van Zuiden M., Geuze E., Willemen H.L., Vermetten E., Maas M., Amarouchi K., et al. Glucocorticoid receptor pathway components predict posttraumatic stress disorder symptom development: a prospective study. Biol Psychiatry 2012, 71:309-316.
46. van Zuiden M., Geuze E., Willemen H.L., Vermetten E., Maas M., Heijnen C.J., et al. Pre-existing high glucocorticoid receptor number predicting development of posttraumatic stress symptoms after military deployment. Am J Psychiatry 2011, 168:89-96.
47. van Zuiden M., Heijnen C.J., van de Schoot R., Amarouchi K., Maas M., Vermetten E., et al. Cytokine production by leukocytes of military personnel with depressive symptoms after deployment to a combat-zone: a prospective, longitudinal study. PLoS One 2011, 6:e29142.
48. Vidovic A., Vilibic M., Sabioncello A., Gotovac K., Rabatic S., Folnegovic-Smalc V., et al. Circulating lymphocyte subsets, natural killer cell cytotoxicity, and components of hypothalamic-pituitary-adrenal axis in Croatian war veterans with posttraumatic stress disorder: cross-sectional study. Croat Med J 2007, 48:198-206.
49. von Kanel R., Hepp U., Kraemer B., Traber R., Keel M., Mica L., et al. Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J Psychiatr Res 2007, 41:744-752.
50. Wang G.J., Volkow N.D., Logan J., Pappas N.R., Wong C.T., Zhu W., et al. Brain dopamine and obesity. Lancet 2001, 357:354-357.
51. Wheler G.H., Brandon D., Clemons A., Riley C., Kendall J., Loriaux D.L., et al. Cortisol production rate in posttraumatic stress disorder. J Clin Endocrinol Metab 2006, 91:3486-3489.
52. Woods A.B., Page G.G., O'Campo P., Pugh L.C., Ford D., Campbell J.C. The mediation effect of posttraumatic stress disorder symptoms on the relationship of intimate partner violence and IFN-gamma levels. Am J Community Psychol 2005, 36:159-175.
53. Yehuda R. Advances in understanding neuroendocrine alterations in PTSD and their therapeutic implications. Ann N Y Acad Sci 2006, 1071:137-166.
54. Yehuda R. Status of glucocorticoid alterations in post-traumatic stress disorder. Ann N Y Acad Sci 2009, 1179:56-69.
55. Yehuda R., Boisoneau D., Lowy M.T., Giller E.L. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry 1995, 52:583-593.
56. Yehuda R., Cai G., Golier J.A., Sarapas C., Galea S., Ising M., et al. Gene expression patterns associated with posttraumatic stress disorder following exposure to the World Trade Center attacks. Biol Psychiatry 2009, 66:708-711.
57. Yehuda R., Golier J.A., Yang R.K., Tischler L. Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biol Psychiatry 2004, 55:1110-1116.
58. Yehuda R., Lowy M.T., Southwick S.M., Shaffer D., Giller E.L. Lymphocyte glucocorticoid receptor number in posttraumatic stress disorder. Am J Psychiatry 1991, 148:499-504.
59. Yehuda R., Yang R.K., Golier J.A., Grossman R.A., Bierer L.M., Tischler L. Effect of sertraline on glucocorticoid sensitivity of mononuclear leukocytes in post-traumatic stress disorder. Neuropsychopharmacology 2006, 31:189-196.
60. Yehuda R., Yang R.K., Golier J.A., Tischler L., Liong B., Decker K. Effect of topiramate on glucocorticoid receptor mediated action. Neuropsychopharmacology 2004, 29:433-439.
61. Yehuda R., Yang R.K., Guo S.L., Makotkine I., Singh B. Relationship between dexamethasone-inhibited lysozyme activity in peripheral mononuclear leukocytes and the cortisol and glucocorticoid receptor response to dexamethasone. J Psychiatr Res 2003, 37:471-477.
62. Zieker J., Zieker D., Jatzko A., Dietzsch J., Nieselt K., Schmitt A., et al. Differential gene expression in peripheral blood of patients suffering from post-traumatic stress disorder. Mol Psychiatry 2007, 12:116-118.